CARNOVALE, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 1.096
NA - Nord America 968
AS - Asia 246
SA - Sud America 4
OC - Oceania 1
Totale 2.315
Nazione #
US - Stati Uniti d'America 968
IT - Italia 313
IE - Irlanda 267
SE - Svezia 254
CN - Cina 123
SG - Singapore 94
UA - Ucraina 55
DE - Germania 48
FI - Finlandia 47
GB - Regno Unito 45
IN - India 23
PL - Polonia 23
BE - Belgio 17
FR - Francia 11
RU - Federazione Russa 7
CH - Svizzera 3
CZ - Repubblica Ceca 3
CL - Cile 2
IR - Iran 2
RO - Romania 2
VN - Vietnam 2
AR - Argentina 1
BR - Brasile 1
ID - Indonesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 2.315
Città #
Dublin 267
Chandler 170
Nyköping 147
Jacksonville 131
Ashburn 81
Singapore 81
Beijing 54
Dearborn 50
Ann Arbor 47
Princeton 42
Cambridge 41
Des Moines 32
Medford 27
Milan 26
Boardman 22
Warsaw 22
Messina 21
Lancaster 19
San Mateo 19
Pune 18
Brussels 16
Rome 14
Norwalk 12
Shenyang 11
Wilmington 11
Los Angeles 10
Woodbridge 8
Bari 7
Jinan 7
Helsinki 6
Catania 5
Guangzhou 5
Haikou 5
Hyderabad 5
Nanjing 5
Bologna 4
Ferrara 4
Monza 4
Padova 4
Pavia 4
Taizhou 4
Bremen 3
Chicago 3
Dundee 3
Florence 3
Hangzhou 3
Hebei 3
Jiaxing 3
Leawood 3
Melzo 3
Nanchang 3
San Giorgio a Cremano 3
Sondrio 3
Tianjin 3
Barletta 2
Borgo San Dalmazzo 2
Brooklyn 2
Cento 2
Ceppaloni 2
Changsha 2
Clifton 2
Crotone 2
Dong Ket 2
Fuzhou 2
Kemerovo 2
Legnano 2
Misterbianco 2
Ningbo 2
Perugia 2
Phoenix 2
Pontassieve 2
Reggio Emilia 2
San Francisco 2
Scicli 2
Vicenza 2
Villaricca 2
Voghera 2
Anguillara Sabazia 1
Ardabil 1
Arzano 1
Belpasso 1
Bergamo 1
Biassono 1
Biella 1
Bilgi 1
Bordighera 1
Borghetto Santo Spirito 1
Brasov 1
Brno 1
Cagliari 1
Calvisano 1
Ceska 1
Chilly-mazarin 1
Christchurch 1
Città Di Castello 1
Comiso 1
Duncan 1
Forest City 1
Grugliasco 1
Grumolo delle Abbadesse 1
Totale 1.576
Nome #
RIDUZIONE DI LATTAMI MEDIANTE REAGENTE DI SCHWARTZ: NUOVA ED EFFICIENTE STRATEGIA SINTETICA DI A-IDROSSICARBAMATI 291
C-5’-Triazolyl-2’-oxa-3’-aza-4’a-carbanucleosides: Synthesis and biological evaluation 99
N,O-Psiconucleosidi Fosfonati “Truncated”. Una Nuova Classe di Agenti Antivirali 83
Evaluation of tea tree oil quality and ascaridole: A deep study by means of chiral and multi heart-cuts multidimensional gas chromatography system coupled to mass spectrometry detection 80
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 75
Sintesi e Attività biologica di nuovi sistemi enediino-isossazolidina coniugati 74
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 71
3-amino-2(5H)furanones: a new class of antiviral agents 68
Enantioseparazione di Analoghi Nucleosidi isossazolidinici 66
A new HPLC method developed for the analysis of oxygen heterocyclic compounds in Citrus essential oils 65
Detemination of oxygen heterocyclic components in citrus products by HPLC with UV detection 64
Sintesi di nuovi inibitori della NS5B Polimerasi di HCV 61
Nucleosidi modificati enantiopuri quali inibitori competitivi della trascrittasi inversa 60
SINTESI E VALUTAZIONE BIOLOGICA DI 3-AMMINO-2(5H)-FURANONI E DI 3-AMMINO-MALEIMMIDI 59
Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents 58
Ottimizzazione di un metodo RP-HPLC per isolare, identificare e quantificare le furanocumarine presenti in matrici naturali 57
Hydrozirconation of four-, five-, six- and seven-memberedN-alkoxycarbonyl lactams to lactamols 53
Truncated phosphonated C-1'-branched N,O-nucleosides: A new class of antiviral agents. 52
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 51
Synthesis of 5-Alkynyl Isoxazolidinyl nucleosides 51
Multidimensional liquid chromatography for the determination of chiral coumarins and furocoumarins in Citrus essential oils 50
Risoluzione biocatalizzata da Lipasi di Nucleosidi Isossazolidinici 49
Determination of Oxygen Heterocyclic Components in Citrus Products by HPLC with UV Detection 47
Analysis of chiral coumarins and furocoumarins in Citrus essential oils by means NP-HPLC 47
Synthesis and biological activity of new arenediyne-linked isoxazolidines 47
DETERMINAZIONE DEL CONTENUTO DI COMPOSTI ETEROCICLICI OSSIGENATIIN DERIVATI AGRUMARI 45
Phosphonated Nucleoside Analogues 45
PREPARATION OF ISOXAZOLIDINYL NUCLEOSIDE ENANTIOMERS BY LIPASE-CATALYSED KINETIC RESOLUTION 44
Synthesis and Biological Activity of Triazole-Appended N,O-Nucleosides 41
Enantiomerically Pure Phosphonated Carbocyclic 2'-Oxa-3'-Azanucleosides: Synthesis and Biological Evaluation 38
Synthesis and Biological Activity of Phosphonated Reverse N,O-Nucleosides 37
Synthesis and Biological Properties of 5-(1H-1,2,3-Triazol-4-yl)isoxazolidines: A New Class of C-Nucleosides 37
3-Amino-2-(5H)Furanones:A New Class of antiviral agents 34
PREPARATION OF ISOXAZOLIDINYL NUCLEOSIDE ENANTIOMERS BY LIPASE-CATALYZED KINETIC RESOLUTION 33
Sintesi ed attività biologica di sistemi isossazolidinil-enediinici 31
Truncated Phosphonated C-1’-Branched N,O-Nucleosides: a new class of antiretroviral agents 30
Risoluzione biocatalizzata da lipasi di N,O -nucleosidi 29
Synthesis and biological evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines 26
Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1reverse transcriptase inhibitors 25
Sintesi e proprietà biologiche di 5-(1H-1,2,3-triazol) isossazolidine 23
Phosphonated N,O-Nucleosides as Antiviral drugs 19
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 19
null 18
Totale 2.352
Categoria #
all - tutte 9.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020215 0 0 0 0 6 46 43 27 8 42 37 6
2020/2021272 29 5 47 18 26 29 13 16 4 30 30 25
2021/2022330 4 61 6 21 16 6 23 14 10 33 52 84
2022/2023755 66 67 36 44 51 76 5 48 334 0 14 14
2023/2024251 19 25 39 57 17 39 3 12 0 19 1 20
2024/2025111 13 12 11 48 27 0 0 0 0 0 0 0
Totale 2.352